6 results on '"Don, Creighton W."'
Search Results
2. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
- Author
-
Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, DiMaio JM, Don CW, Fremes SE, Gaudino MF, Goldberger ZD, Grant MC, Jaswal JB, Kurlansky PA, Mehran R, Metkus TS Jr, Nnacheta LC, Rao SV, Sellke FW, Sharma G, Yong CM, and Zwischenberger BA
- Subjects
- American Heart Association organization & administration, Coronary Artery Bypass methods, Coronary Artery Disease physiopathology, Coronary Artery Disease therapy, Coronary Vessels surgery, Humans, United States, Vascular Surgical Procedures methods, Cardiology standards, Coronary Artery Bypass standards, Myocardial Revascularization standards, Percutaneous Coronary Intervention standards, Vascular Surgical Procedures standards
- Abstract
Aim: The executive summary of the American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions coronary artery revascularization guideline provides the top 10 items readers should know about the guideline. In the full guideline, the recommendations replace the 2011 coronary artery bypass graft surgery guideline and the 2011 and 2015 percutaneous coronary intervention guidelines. This summary offers a patient-centric approach to guide clinicians in the treatment of patients with significant coronary artery disease undergoing coronary revascularization, as well as the supporting documentation to encourage their use., Methods: A comprehensive literature search was conducted from May 2019 to September 2019, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, CINHL Complete, and other relevant databases. Additional relevant studies, published through May 2021, were also considered. Structure: Recommendations from the earlier percutaneous coronary intervention and coronary artery bypass graft surgery guidelines have been updated with new evidence to guide clinicians in caring for patients undergoing coronary revascularization. This summary includes recommendations, tables, and figures from the full guideline that relate to the top 10 take-home messages. The reader is referred to the full guideline for graphical flow charts, supportive text, and tables with additional details about the rationale for and implementation of each recommendation, and the evidence tables detailing the data considered in the development of this guideline.
- Published
- 2022
- Full Text
- View/download PDF
3. Recent Trends in Adherence to Secondary Prevention Guidelines for Patients Undergoing Coronary Revascularization in Washington State: An Analysis of the Clinical Outcomes Assessment Program (COAP) Registry.
- Author
-
Riley RF, Don CW, Aldea GS, Mokadam NA, Probstfield J, Maynard C, and Goss JR
- Subjects
- Adrenergic beta-Antagonists therapeutic use, Aged, Angiotensin Receptor Antagonists therapeutic use, Angiotensin-Converting Enzyme Inhibitors therapeutic use, Aspirin therapeutic use, Female, Humans, Hypolipidemic Agents therapeutic use, Male, Middle Aged, Myocardial Infarction therapy, Outcome Assessment, Health Care, Quality Improvement, Registries, Retrospective Studies, Washington, Coronary Artery Bypass rehabilitation, Guideline Adherence, Patient Compliance, Percutaneous Coronary Intervention rehabilitation, Secondary Prevention standards
- Abstract
Background: Previous studies indicated that patients undergoing coronary artery bypass graft (CABG) surgery are less likely to receive guideline-based secondary prevention therapy than are those undergoing percutaneous coronary intervention (PCI) after an acute myocardial infarction. We aimed to evaluate whether these differences have persisted after the implementation of public reporting of hospital metrics., Methods and Results: The Clinical Outcomes Assessment Program (COAP) database was analyzed retrospectively to evaluate adherence to secondary prevention guidelines at discharge in patients who underwent coronary revascularization after an acute ST-elevation myocardial infarction in Washington State. From 2004 to 2007, 9260 patients received PCI and 692 underwent CABG for this indication. Measures evaluated included prescription of aspirin, β-blockers, angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, or lipid-lowering medications; cardiac rehabilitation referral; and smoking-cessation counseling. Composite adherence was lower for CABG than for PCI patients during the period studied (79.6% versus 89.7%, P<0.01). Compared to patients who underwent CABG, patients who underwent PCI were more likely to receive each of the pharmacological therapies. There was no statistical difference in smoking-cessation counseling (91.7% versus 90.3%, P=0.63), and CABG patients were more likely to receive referral for cardiac rehabilitation (70.9% versus 48.3%, P<0.01). Adherence rates improved over time among both groups, with no significant difference in composite adherence in 2006 (85.6% versus 87.6%, P=0.36)., Conclusions: Rates of guideline-based secondary prevention adherence in patients with ST-elevation myocardial infarction who underwent CABG surgery have been improving steadily in Washington State. The improvement possibly is associated with the implementation of public reporting of quality measures., (© 2012 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley-Blackwell. This is an Open Access article under the terms of the Creative Commons Attribution Noncommercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.)
- Published
- 2012
- Full Text
- View/download PDF
4. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
- Author
-
Lawton, Jennifer S. Chair, Tamis-Holland, Jacqueline E. FACC, FSCAI, Vice Chair, Bangalore, Sripal MHA, FACC, FSCAI, Bates, Eric R. FACC, FAHA, Beckie, Theresa M. FAHA, Bischoff, James M. MEd, Bittl, John A. FACC, Cohen, Mauricio G. FACC, FSCAI, DiMaio, J. Michael, Don, Creighton W. FACC, Fremes, Stephen E. FACC, Gaudino, Mario F. FACC, FAHA, Goldberger, Zachary D. FACC, FAHA, Grant, Michael C. MSE, Jaswal, Jang B. MS, Kurlansky, Paul A. FACC, Mehran, Roxana FACC, Metkus, Thomas S. Jr FACC, Nnacheta, Lorraine C. DrPH,, and Rao, Sunil V. FACC
- Subjects
- *
CARDIOGENIC shock , *CORONARY arteries , *MEDICAL personnel , *CORONARY artery bypass - Abstract
Keywords: AHA Scientific Statements; percutaneous coronary intervention; angioplasty; coronary artery bypass graft surgery; myocardial infarction; cardiac surgery; stent(s); angiogram; angiography; percutaneous transluminal coronary angioplasty; coronary atherosclerosis; saphenous vein graft; internal mammary artery graft; internal thoracic artery graft; arterial graft; post-bypass; non-ST-segment-elevated myocardial infarction; vein graft lesions; myocardial revascularization; multivessel PCI; left ventricular dysfunction EN AHA Scientific Statements percutaneous coronary intervention angioplasty coronary artery bypass graft surgery myocardial infarction cardiac surgery stent(s) angiogram angiography percutaneous transluminal coronary angioplasty coronary atherosclerosis saphenous vein graft internal mammary artery graft internal thoracic artery graft arterial graft post-bypass non-ST-segment-elevated myocardial infarction vein graft lesions myocardial revascularization multivessel PCI left ventricular dysfunction e18 e114 97 01/21/22 20220118 NES 220118 SP * sp Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendix 1 for detailed information. Patients who are most appropriate for complete revascularization at the time of primary PCI include those with uncomplicated PCI of the infarct artery and with low-complexity non-infarct artery disease who have normal left ventricular filling pressures and normal renal function. Recommendation-Specific Supportive Text After controlling for greater baseline comorbidities among patients undergoing revascularization, several observational studies have demonstrated that Black,[28],[52] Hispanic,[24],[50] and Asian [55],[56] patients have outcomes similar to those of White patients. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF
5. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
- Author
-
Lawton, Jennifer S., Tamis-Holland, Jacqueline E., Bangalore, Sripal, Bates, Eric R., Beckie, Theresa M., Bischoff, James M., Bittl, John A., Cohen, Mauricio G., DiMaio, J. Michael, Don, Creighton W., Fremes, Stephen E., Gaudino, Mario F., Goldberger, Zachary D., Grant, Michael C., Jaswal, Jang B., Kurlansky, Paul A., Mehran, Roxana, Metkus, Thomas S., Nnacheta, Lorraine C., and Rao, Sunil V.
- Subjects
- *
CORONARY artery bypass , *CORONARY arteries , *PERCUTANEOUS coronary intervention , *TRANSLUMINAL angioplasty , *CORONARY artery disease , *READING strategies , *DIABETES , *RISK assessment , *MYOCARDIAL revascularization , *HEALTH care teams , *ALGORITHMS - Abstract
Aim: The executive summary of the American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions coronary artery revascularization guideline provides the top 10 items readers should know about the guideline. In the full guideline, the recommendations replace the 2011 coronary artery bypass graft surgery guideline and the 2011 and 2015 percutaneous coronary intervention guidelines. This summary offers a patient-centric approach to guide clinicians in the treatment of patients with significant coronary artery disease undergoing coronary revascularization, as well as the supporting documentation to encourage their use.Methods: A comprehensive literature search was conducted from May 2019 to September 2019, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, CINHL Complete, and other relevant databases. Additional relevant studies, published through May 2021, were also considered.Structure: Recommendations from the earlier percutaneous coronary intervention and coronary artery bypass graft surgery guidelines have been updated with new evidence to guide clinicians in caring for patients undergoing coronary revascularization. This summary includes recommendations, tables, and figures from the full guideline that relate to the top 10 take-home messages. The reader is referred to the full guideline for graphical flow charts, supportive text, and tables with additional details about the rationale for and implementation of each recommendation, and the evidence tables detailing the data considered in the development of this guideline. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
6. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
- Author
-
Lawton, Jennifer S., Tamis-Holland, Jacqueline E., Bangalore, Sripal, Bates, Eric R., Beckie, Theresa M., Bischoff, James M., Bittl, John A., Cohen, Mauricio G., DiMaio, J. Michael, Don, Creighton W., Fremes, Stephen E., Gaudino, Mario F., Goldberger, Zachary D., Grant, Michael C., Jaswal, Jang B., Kurlansky, Paul A., Mehran, Roxana, Metkus, Thomas S., Nnacheta, Lorraine C., and Rao, Sunil V.
- Subjects
- *
CORONARY artery bypass , *CORONARY arteries , *CARDIOPULMONARY bypass , *CORONARY artery disease , *PERCUTANEOUS coronary intervention , *HEART , *CARDIOLOGY , *SYSTEMATIC reviews , *MYOCARDIAL revascularization - Abstract
Aim: The guideline for coronary artery revascularization replaces the 2011 coronary artery bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines, providing a patient-centric approach to guide clinicians in the treatment of patients with significant coronary artery disease undergoing coronary revascularization as well as the supporting documentation to encourage their use.Methods: A comprehensive literature search was conducted from May 2019 to September 2019, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, CINHL Complete, and other relevant databases. Additional relevant studies, published through May 2021, were also considered.Structure: Coronary artery disease remains a leading cause of morbidity and mortality globally. Coronary revascularization is an important therapeutic option when managing patients with coronary artery disease. The 2021 coronary artery revascularization guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with coronary artery disease who are being considered for coronary revascularization, with the intent to improve quality of care and align with patients' interests. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.